Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Omeros patents new anti-MASP-2 monoclonal antibodies

Dec. 7, 2012

Varenicline as a potential treatment for methamphetamine dependence

Dec. 7, 2012

Phase IIa trial begins of MediciNova's ibudilast

Nov. 22, 2012

FDA assigns action date for Orexo's Zubsolv NDA

Nov. 19, 2012

Catalyst Pharmaceutical reports results from phase IIb CPP-109 trial

Nov. 9, 2012

ADX-71441 shows promise in preclinical model of alcohol binge drinking

Oct. 30, 2012

DepoVax found to enhance effect of investigational cocaine vaccine

Oct. 26, 2012

Nabi Biopharmaceuticals reports results from phase II NicVAX vaccine study

Oct. 18, 2012

Reckitt Benckiser to discontinue supply of Suboxone tablets in U.S.

Sep. 28, 2012

University of Pittsburg presents new radioprotectants

Sep. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...